VEGFA and ovarian hyperstimulation syndrome: VEGF-mediated VP is thought to act through KDR-dependent mechanisms and dopamine/dopamine receptor agonists [27,36], which purportedly inhibit KDR function, have shown promise as therapies for OHSS [27,39,42-44].